Cancer Therapy

During a shareholder presentation in front of more than 500 physicians in April, Debra A. Patt, MD, PhD, MBA, FASCO, asked how many in attendance used large language models like ChatGPT and Claude.

Oregon Health & Science University has implemented a “symptom science” clinical research program designed to mitigate toxicities and improve quality of life for people with cancer.

The addition of a pre-ketone supplement to an immunotherapy regimen demonstrated efficacy for treating prostate cancer, according to a study led by researchers at University of Notre Dame.

Certain physical exercises may prevent nerve damage caused by chemotherapy among individuals being treated for cancer, results of a randomized study published in JAMA Internal Medicine showed.

Individuals with therapy-refractory cancer who received waivers to participate in a clinical trial for off-label targeted therapies achieved similar clinical benefits as those who took part in the study without an exception.

CHICAGO — A stepped palliative care model delivering early care at key points for patients with advanced cancer resulted in fewer visits while still maintaining quality-of-life benefits, results from a randomized study showed.

Patients with cancer who received specialized mental health support experienced improved quality of life, as well as reduced pain, depression and fatigue.

CHICAGO — Healio once again welcomed the excitement of the Disruptive Innovator Awards, working with new partners and celebrating nine distinct areas of progress in oncology and hematology.

William Dale, MD, PhD, FASCO, has experienced a range of emotions since learning he’d receive the B.J. Kennedy Geriatric Oncology Award at this year’s ASCO Annual Meeting.

Age-related changes to the skin’s elasticity may drive higher rates of metastatic skin cancer among older individuals, according to study results.